![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Shodhana Laboratories Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
They are recognized for Shodhana continues to entrench its position on R&D, scale-up and commercialization of APIs, with supplies to 50+ countries.
One of their significant offerings is Escitalopram oxalate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-278 - Rev 01
This Chemical Type CEP, issued on February 08, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2733 associated with this CEP further emphasizes